Last Posted: Oct 18, 2018
- Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer.
Yang Lingjian et al. EBioMedicine 2018 May 31182-189 - Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer.
Carter H Ballentine et al. European urology 2018 Oct - Practical Methods for Integrating Genetic Testing Into Clinical Practice for Advanced Prostate Cancer.
Cheng Heather et al. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2018 May (38) 372-381 - Providing clinicians and patients with important information to help guide decisions about prostate cancer screening.
USPSTF, October 8, 2018 - New supplemental awards boost NIH funding for research on Down syndrome
NIH, October 1, 2018 - A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial Biopsy.
McKiernan James et al. European urology 2018 Sep - Interest in, willingness-to-pay for and willingness-to-recommend genetic testing for prostate cancer among affected men after radical prostatectomy.
Mayer Marcel et al. Familial cancer 2018 Sep - Noncoding RNA for personalized prostate cancer treatment: utilizing the 'dark matters' of the genome.
Hua Junjie et al. Personalized medicine 2017 14(2) 159-169 - Genetic Counseling Recommended for Advanced Prostate Cancer
M Dalton, Prostate Cancer Advisor, September 17, 2018 - Precision medicine approaches when prostate cancer Akts up.
Zhang Tian et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Sep
.png)
No hay comentarios:
Publicar un comentario